132 related articles for article (PubMed ID: 38048919)
1. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
Cartwright M; Toit RL; Africander D
Biochem Biophys Res Commun; 2023 Jan; 639():70-76. PubMed ID: 36470074
[TBL] [Abstract][Full Text] [Related]
4. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
5. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor.
Cartwright M; Louw-du Toit R; Jackson H; Janse van Vuuren M; Africander D
J Steroid Biochem Mol Biol; 2023 Sep; 232():106348. PubMed ID: 37315868
[TBL] [Abstract][Full Text] [Related]
7. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
[TBL] [Abstract][Full Text] [Related]
9. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.
Skosana SB; Woodland JG; Cartwright M; Enfield K; Komane M; Louw-du Toit R; van der Spuy Z; Avenant C; Africander D; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2019 May; 189():145-153. PubMed ID: 30822501
[TBL] [Abstract][Full Text] [Related]
10. A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor.
Louw-du Toit R; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2020 May; 526(2):466-471. PubMed ID: 32234237
[TBL] [Abstract][Full Text] [Related]
11. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
12. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
13. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
14. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
15. [The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
Giulianelli S; Vaqué JP; Wargon V; Soldati R; Vanzulli SI; Martins R; Zeitlin E; Helguero L; Lamb C; Molinolo AA; Gutkind JS; Lanari C
Medicina (B Aires); 2012; 72(4):315-20. PubMed ID: 22892083
[TBL] [Abstract][Full Text] [Related]
16. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
18. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
[TBL] [Abstract][Full Text] [Related]
19. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
20. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Huijbregts RP; Michel KG; Hel Z
Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
